Voyager Therapeutics Inc (VYGR)
EBITDA Margin
-743.92%
Quarterly · Period ending:
VYGR EBITDA Margin
Latest reported-743.92%period ending
Latest reported-743.92%period ending
VYGR Quarterly EBITDA Margin (0.00% → -743.92%)
Quarterly ebitda margin
High-resolution chart · PNG
VYGR ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -743.9179% | |
| -1,040.9179% | |
| -171.9353% | |
| -201.0999% | |
| -621.1923% | |
| -463.0002% | |
| -523.9248% | |
| -31.9501% | |
| -29.4983% | |
| -51.8549% | |
| 65.0137% | |
| -537.0395% | |
| -434.0202% | |
| 83.6144% | |
| 1,469.4194% | |
| 46.1593% | |
| -2,511.6573% | |
| -2,812.614% | |
| 27.9058% | |
| -1,613.5628% | |
| -2,132.2771% | |
| -374.0194% | |
| -347.8966% | |
| 72.6297% | |
| -28.0848% | |
| -130.5751% | |
| -39.8176% | |
| -83.649% | |
| 25.6667% | |
| -551.7991% | |
| -1,093.2769% | |
| -982.8558% | |
| -971.8447% | |
| -2,190.7643% | |
| -187.7384% | |
| -1,996.6899% | |
| -1,548.853% | |
| -1,175.2049% | |
| -579.0855% | |
| -308.6759% | |
| -254.4624% | |
| -151.7805% | |
| -147.3769% | |
| -78.1649% | |
| -78.2555% | |
| -182.337% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |